Phase 3 Readout

Phase 3 Topline: An Open Label Extension Study of Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular

Indication
Paroxysmal Supraventricular Tachycardia

Other upcoming events for MIST

Phase 3 ReadoutPhase 3 Topline: Multi-Center, Placebo-Controlled, Phase 3 Study of Etripamil Nasal Spray (NS) in Patients With Atria
Patent ExpiryPatent/Exclusivity Expiry: CARDAMYST

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: An Open Label Extension Study of Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular — MIST Phase 3 Readout | BioSniper